HEALTHSTAT NEWS
STAT+: Medicare’s mum on GLP-1s, and Massachusetts sues United
Medicare is promoting GLP-1 drugs Wegovy and Zepbound for weight loss starting July 2024 at $50/month for older adults but has not disclosed the total cost to taxpayers. Massachusetts has filed a lawsuit against United, though details are unspecified in the excerpt.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Medicare still won’t say how much covering obesity drugs will cost
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- STAT+: Pharmalittle: We’re reading about pharma lobbying, Bristol’s deal with a Chinese partner, and more
- STAT+: French regulator fines Novo and Lilly over weight loss ad campaigns
- Family sues OpenAI, alleging ChatGPT advice led to accidental overdose
- STAT+: Massachusetts sues UnitedHealth, alleging fraud in state’s Medicaid plans for seniors